Ursula Grohmann

Prof. Ursula Grohmann

University of Perugia, Department of Experimental Medicine
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2003 in Nature Immunology
Verified
Journal Article
Closed access
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
UGUrsula Grohmann
Ursula Grohmann
KHKwang Woo Hwang
Kwang Woo Hwang
COCiriana Orabona
Ciriana Orabona
CVCarmine Vacca
Carmine Vacca
Paolo PuccettiPaolo Puccetti
Paolo Puccetti

30 September 2002 in Nature Immunology
Verified
Journal Article
Closed access
UGUrsula Grohmann
Ursula Grohmann
COCiriana Orabona
Ciriana Orabona
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
CVCarmine Vacca
Carmine Vacca
FCFilippo Calcinaro
Filippo Calcinaro
Paolo PuccettiPaolo Puccetti
Paolo Puccetti

1 June 2006 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
UGUrsula Grohmann
Ursula Grohmann
SYSylvaine You
Sylvaine You
BMBarbara C. McGrath
Barbara C. McGrath
DCDouglas R. Cavener
Douglas R. Cavener
Paolo PuccettiPaolo Puccetti
Paolo Puccetti
Tryptophan catabolism is a tolerogenic effector system in regulatory T cell function, yet the general mechanisms whereby tryptophan catabolism affects T cell responses remain unclear. We provide evidence that the short-term, combined effects of tryptophan deprivation and tryptophan catabolites result in GCN2 kinase-dependent down-regulation of the TCR ζ-chain in murine CD8+ T cells. TCR ζ down-regulation can be demonstrated in vivo and is associated with an impaired cytotoxic effector function in vitro. The longer-term effects of tryptophan catabolism include the emergence of a regulatory phenotype in naive CD4+CD25− T cells via TGF-β induction of the forkhead transcription factor Foxp3. Such converted cells appear to be CD25+, CD69−, CD45RBlow, CD62L+, CTLA-4+, BTLAlow and GITR+, and are capable of effective control of diabetogenic T cells when transferred in vivo. Thus, both tryptophan starvation and tryptophan catabolites contribute to establishing a regulatory environment affecting CD8+ as well as CD4+ T cell function, and not only is tryptophan catabolism an effector mechanism of tolerance, but it also results in GCN2-dependent generation of autoimmune-preventive regulatory T cells.

1 October 2002 in Cell Death & Differentiation
Verified
Journal Article
Closed access
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
UGUrsula Grohmann
Ursula Grohmann
CVC Vacca
C Vacca
RBR Bianchi
R Bianchi
COCiriana Orabona
Ciriana Orabona
Paolo PuccettiPaolo Puccetti
Paolo Puccetti

9 July 2014 in Nature
Verified
Journal Article
Closed access
PDF file
ABAlban Bessede
Alban Bessede
Marco GargaroMarco Gargaro
Marco Gargaro
MPMaria Teresa Pallotta
Maria Teresa Pallotta
DMDavide Matino
Davide Matino
GSGiuseppe Servillo
Giuseppe Servillo
Paolo PuccettiPaolo Puccetti
Paolo Puccetti

31 July 2011 in Nature Immunology
Verified
Journal Article
Closed access
MPMaria Teresa Pallotta
Maria Teresa Pallotta
COCiriana Orabona
Ciriana Orabona
CVClaudia Volpi
Claudia Volpi
CVCarmine Vacca
Carmine Vacca
MBMaria Laura Belladonna
Maria Laura Belladonna
UGUrsula Grohmann
Ursula Grohmann